Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
Clinical trial NCT04046185 · UNKNOWN
Trial details
- NCT number
- NCT04046185
- Sponsor
- Shanghai First Maternity and Infant Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.